Advancement in Scaffold-Based 3D Cell Culture Models for Osteosarcoma Drug Screening
Mandeda Madaiah P., Ghosh RN., Namboothiri PK., Peter M.
Narrative Review, published in ACS Biomater Sci Eng (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- ACS Biomater Sci Eng (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41139822
- PMCID
- PMC12606569
- DOI
- 10.1021/acsbiomaterials.5c01174
- Citations
- 1
Abstract (original English)
Osteosarcoma (OS), an extremely aggressive bone cancer that primarily occurs in children and teenagers, continues to pose critical clinical challenges due to its high propensity for metastasis, resistance to conventional therapies, and lack of specific biomarkers for early detection. Despite advances in surgical techniques and chemotherapeutic regimens, patient outcomes remain suboptimal, predominantly because conventional two-dimensional (2D) cell culture systems do not accurately mimic the intricate tumor microenvironment (TME), which often results in limited success when translating preclinical results to clinical success. In response to the shortcomings, the field has shifted toward three-dimensional (3D) culture systems, which more accurately mimic the spatial, mechanical, and biochemical characteristics of native OS TME. This review systematically examines the evolution and current state of 3D OS models, with a particular focus on scaffold-based systems. These models, utilizing biomimetic scaffolds provide enhanced platforms for studying tumor-stroma interactions, drug responses, and chemoresistance. It also briefs the use of scaffold-free spheroid models, which, despite their utility in replicating certain aspects of tumor heterogeneity and cell-cell interactions, are limited in their ability to fully emulate the in vivo microenvironment. The review further discusses tec
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.